Whether it’s climbing stairs, chasing kids, or staying committed to a favorite workout, movement shapes everyday life. As more people look for lasting comfort and resilience, science is bringing forward new possibilities. The focus is shifting beyond temporary relief toward solutions that support the body’s natural ability to strengthen and renew.
It is within this environment that ZyCal Bioceuticals Healthcare Co., Inc. has built its purpose. The organization emerged with a deep understanding of orthopedic biology and a commitment to translating that science into accessible, everyday tools for wellness. While many supplement companies focus on cushioning joints or supplying minerals, ZyCal’s work is rooted in regenerative mechanisms that have been studied globally by scientists and used by surgeons in operating rooms for decades. Their approach has introduced a different way of thinking about bone and cartilage care. Instead of simply supporting the structures that already exist, they sought to find biological solutions that have shown to encourage the body to renew and rebuild them.
This mission is guided by James J. Scaffidi, D.N.M.c., B.Sc., who serves as President and CEO. His leadership brings together scientific insight, industry experience, and a forward-looking vision for regenerative health and medicine. Under his direction, the company has expanded its role as a pioneer in the development of oral growth-factor complexes, creating a path for everyday individuals to benefit from discoveries that were once available only in advanced orthopedic surgery.
The story of ZyCal is a story of scientific translation, clinical inspiration, and a belief that bone and joint health can be reimagined for future generations. Let’s delve into it!
Origins Shaped by Orthopedic Surgery and Research
The roots of the company can be traced to the orthopedic spine and bone biology community where surgeons had spent decades studying how to stimulate skeletal regeneration. Long before nutraceuticals were part of the equation, medical teams were using bone extracts which contain growth-factors known as bone morphogenetic proteins, known as BMPs, to promote fusion and post-operative healing. These growth-factors, known as specialized proteins, had the remarkable ability to activate mesenchymal stem cells and guide those cells toward becoming bone-forming osteoblasts or cartilage-forming chondrocytes. In complex spinal surgeries and bone grafting procedures, these bone extracts known as BMP-complexes became essential tools that significantly improved patient outcomes.
Yet, despite their success in surgical environments, BMP-complexes remained confined to those settings. They had to be implanted directly into the body in order to initiate the regenerative cascade and were limited in use to fractures and fusions. As a result, patients seeking long-term bone and joint support in everyday life could not access the powerful biology that surgeons relied upon. The founders of ZyCal saw this limitation clearly. They recognized that the science behind BMPs was too valuable to keep exclusively within operating rooms. They asked themselves whether it would be possible to adapt the regenerative potential of these BMP-complexes into a natural nutraceutical format that could be taken orally rather than surgically implanted and used to support healthy bones and joints.
This line of thinking was influenced by earlier scientific breakthroughs. In the mid-1960s, Dr. Marshall Urist published research describing how specific proteins within bone extracts could trigger new bone formation when placed into living tissue. This discovery laid the foundation for the field of orthopedic regenerative medicine. Over the following decades, BMP-complexes became celebrated for their ability to stimulate tissue formation. As science progressed and recombinant BMPs became more widely studied, orthopedic specialists began to rely on these singular specific proteins to achieve skeletal healing where traditional treatments struggled.
ZyCal was born out of this history. The founders believed that if BMP-complexes could drive regeneration in surgical environments, then a natural BMP-complex extracted from an organic food-source, might offer similar biological advantages through oral use. Their goal was to build a bridge between orthopedic science and everyday wellness by delivering regenerative signals that were once available only through medical intervention.
Adapting Surgical Biology for Oral Use
Traditional BMP-complexes used in surgery required precise placement at the site of injury or where fusion, such as spinal fusion, was needed. These materials interacted directly with the surrounding tissue and initiated a highly coordinated series of biological events that resulted in bone formation. To replicate this process outside the surgical environment, ZyCal needed to create an orally delivered complex that preserved the natural signaling environment found in bone-extract but in a form that could be absorbed or interact safely through the digestive system.
This work led ZyCal’s development of Cyplexinol®, a natural complex of bone-derived growth factors that include BMPs and other proteins essential to skeletal formation. Cyplexinol® is sourced from certified organic bovine bone and processed under controlled conditions designed to maintain the activity of the growth-factor complex. Every batch is certified by an independent laboratory to turn on stem cells and grow new bone and cartilage tissue – the same rigorous certification that medical companies use before implanting these complexes into patients.
The result is a biologically active complex that goes beyond minerals or collagen alone as they only provide simple building blocks to passively support structure, whereas Cyplexinol® provides active signaling that targets the bone and cartilage building pathways. This innovation marked a turning point for the entire category of bone and joint supplements. For the first time, consumers can access a natural oral complex that was designed to influence the same pathways orthopedic surgeons had been using for decades.
Introducing the Ostinol® Brand of Products
To bring the Cyplexinol® ingredient to market, the company launched its own brand of products called Ostinol® Bone and Cartilage Stimulating Proteins. Within the Ostinol® brand is a product line focused on bone health, targeting the bone-building pathways supporting the body’s ability to activate and transform stem cells into osteoblasts. The cells in turn have been shown to make new bone tissue, the critical framework inside of our bones so calcium and other minerals can bind.
Then they created a line of joint health products featuring Cyplexinol® ingredient along with other nutrients shown to support both joint comfort and the body’s ability to regenerate cartilage.
The consumer line of products includes formulas for everyday support as well as specialized products tailored for people under greater strain. There are options for individuals looking for fast comfort in weight bearing joints and higher dose variations for athletes, older adults, or those recovering from injury. Although each formula is crafted for a specific purpose, all share the same core principle. They aim to offer short-term comfort while contributing to long-term structural resilience by activating the body’s natural regenerative processes.
This design reflects an understanding of how real people live. Many individuals want to remain active but struggle with stiffness or discomfort during daily activities. Others are looking for ways to support their joint health as they age or increase physical training. Ostinol® provides a spectrum of options that meet people where they are and provide support to help guide them toward better musculoskeletal health over time.
Advanced Formulas for Clinical Use
Because bone and joint conditions can vary widely in severity, ZyCal developed an advanced line of practitioner only products. These formulas contain higher concentrations of Cyplexinol® and are intended for use under the guidance of healthcare professionals such as integrative physicians, chiropractors, and naturopathic doctors.
This allows regenerative nutrition to be applied in a precise and targeted manner. Practitioners can adjust strengths over time, increase support as healthcare practitioners see fit, along with maintenance level – all focused on supporting bone and joint health.
What the Studies Show
Research on the Cyplexinol® ingredient as well as Ostinol® brand products combines lab research, clinical trials, and real-world results. BMP-complexes are known to stimulate dormant stem cells, activating and transforming them into osteoblasts and chondrocytes so the body can build new bone and cartilage. Cyplexinol® is the first and only oral BMP-complex and it is through scientific and technical expertise that the manufacturing team is able to preserve the growth factors in the complex, allowing this novel, oral ingredient to support these natural regenerative pathways.
In a University of Memphis study, 18 adults with knee or hip pain took 900 mg of Cyplexinol® daily for 14 days. Participants reported significant reductions in pain and stiffness and improved function compared with placebo (Pence et al., J Clin Transl Res, 2023;9:212–221).
In limited, well-controlled extended case-studies of Cyplexinol® for bone health, measurable increases in bone mineral density have been observed in limited case reports. Many users have reported satisfying clinical results with Cyplexinol® in the form of Ostinol®, sharing that their bone loss has stopped or slowed down and some have reported increases in their DEXA scores.
Preclinical studies confirm that BMP-complexes can generate new bone and cartilage in vivo. Together, these findings suggest that Ostinol®, powered by Cyplexinol® – the only oral BMP-complex, supports the body’s natural regenerative processes rather than acting as supplement.
Patient and Practitioner Insights
The benefits of Ostinol® are reflected in real experiences. People with joint stiffness or discomfort often notice improvements within days with rapid comfort formulas or see gradual progress over several weeks. These changes help restore confidence and make everyday activities easier.
Long-term users focused on bone health report stable or improved DEXA scores, sometimes exceeding expectations for their age. Many credit the combination of lifestyle strategies and Ostinol® for these results.
Practitioners also see value in the advanced formulas. Integrative clinicians report incorporate Ostinol® into treatment plans for osteoarthritis, chronic joint pain, and complex skeletal issues. They adjust strength based on patient needs, using regenerative nutrition as an active part of care rather than just a calcium supplement.
A New Vision for Bone and Joint Health
Scaffidi offers a practical, forward-thinking view of regenerative medicine. He believes the next era of bone and joint care will go beyond managing discomfort and will focus on rebuilding tissue in ways once possible only through advanced medical procedures. Oral growth factor complexes are an early part of this shift because they provide an accessible way to support the body’s regenerative pathways according to Scaffidi.
A key part of his outlook is integration. Regenerative nutrition is most effective when it works alongside other approaches such as physical therapy, biomechanical correction, weight-bearing exercise, anti-inflammatory nutrition, and when needed, surgical or biologic treatment. Scaffidi sees oral growth-factor complexes complementing these strategies by supporting long-term stability and helping protect surrounding joints and bone.
He also emphasizes personalization. With different strengths and clinician-guided formulas, regenerative nutrition can be tailored to each individual. This fits with the broader movement toward precision medicine. Zycal’s approach supports early action for people at risk, more targeted support for those with active degeneration, and maintenance plans once progress is made.
One of the most compelling parts of his vision is extending the bone and joint health span. He imagines a future where people stay mobile and independent longer, have fewer fractures, and possibly delay or even avoid joint replacement. Natural growth-factor complexes such as Cyplexinol® highlight the opportunities to support the body’s regenerative pathways, demonstrating the potential of Ostinol® in advancing bone and joint health.
